Literature DB >> 33218969

A High-Content Screen Identifies Drugs That Restrict Tumor Cell Extravasation across the Endothelial Barrier.

Georg Hilfenhaus1, Ana Mompeón2, Jonathan Freshman1, Divya P Prajapati1, Gloria Hernandez3, Vanessa M Freitas4, Feiyang Ma3, Adam D Langenbacher1, Snezana Mirkov2, Dana Song1, Byoung-Kyu Cho5, Young Ah Goo5, Matteo Pellegrini1,3, Jau-Nian Chen1,3, Robert Damoiseaux6,7,8, M Luisa Iruela-Arispe9,2,3,8.   

Abstract

Metastases largely rely on hematogenous dissemination of tumor cells via the vascular system and significantly limit prognosis of patients with solid tumors. To colonize distant sites, circulating tumor cells must destabilize the endothelial barrier and transmigrate across the vessel wall. Here we performed a high-content screen to identify drugs that block tumor cell extravasation by testing 3,520 compounds on a transendothelial invasion coculture assay. Hits were further characterized and validated using a series of in vitro assays, a zebrafish model enabling three-dimensional (3D) visualization of tumor cell extravasation, and mouse models of lung metastasis. The initial screen advanced 38 compounds as potential hits, of which, four compounds enhanced endothelial barrier stability while concurrently suppressing tumor cell motility. Two compounds niclosamide and forskolin significantly reduced tumor cell extravasation in zebrafish, and niclosamide drastically impaired metastasis in mice. Because niclosamide had not previously been linked with effects on barrier function, single-cell RNA sequencing uncovered mechanistic effects of the drug on both tumor and endothelial cells. Importantly, niclosamide affected homotypic and heterotypic signaling critical to intercellular junctions, cell-matrix interactions, and cytoskeletal regulation. Proteomic analysis indicated that niclosamide-treated mice also showed reduced levels of kininogen, the precursor to the permeability mediator bradykinin. Our findings designate niclosamide as an effective drug that restricts tumor cell extravasation through modulation of signaling pathways, chemokines, and tumor-endothelial cell interactions. SIGNIFICANCE: A high-content screen identified niclosamide as an effective drug that restricts tumor cell extravasation by enhancing endothelial barrier stability through modulation of molecular signaling, chemokines, and tumor-endothelial cell interactions. GRAPHICAL ABSTRACT: http://cancerres.aacrjournals.org/content/canres/81/3/619/F1.large.jpg. ©2020 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33218969      PMCID: PMC7916904          DOI: 10.1158/0008-5472.CAN-19-3911

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   13.312


  51 in total

1.  A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays.

Authors: 
Journal:  J Biomol Screen       Date:  1999

2.  Structure-activity analysis of niclosamide reveals potential role for cytoplasmic pH in control of mammalian target of rapamycin complex 1 (mTORC1) signaling.

Authors:  Bruno D Fonseca; Graham H Diering; Michael A Bidinosti; Kush Dalal; Tommy Alain; Aruna D Balgi; Roberto Forestieri; Matt Nodwell; Charles V Rajadurai; Cynthia Gunaratnam; Andrew R Tee; Franck Duong; Raymond J Andersen; John Orlowski; Masayuki Numata; Nahum Sonenberg; Michel Roberge
Journal:  J Biol Chem       Date:  2012-04-02       Impact factor: 5.157

3.  Tumour-cell-induced endothelial cell necroptosis via death receptor 6 promotes metastasis.

Authors:  Boris Strilic; Lida Yang; Julián Albarrán-Juárez; Laurens Wachsmuth; Kang Han; Ulrike C Müller; Manolis Pasparakis; Stefan Offermanns
Journal:  Nature       Date:  2016-08-03       Impact factor: 49.962

Review 4.  The plasma bradykinin-forming pathways and its interrelationships with complement.

Authors:  Allen P Kaplan; Berhane Ghebrehiwet
Journal:  Mol Immunol       Date:  2010-08       Impact factor: 4.407

5.  Endothelial Tie1-mediated angiogenesis and vascular abnormalization promote tumor progression and metastasis.

Authors:  Silvia La Porta; Lise Roth; Mahak Singhal; Carolin Mogler; Carleen Spegg; Benjamin Schieb; Xianghu Qu; Ralf H Adams; H Scott Baldwin; Soniya Savant; Hellmut G Augustin
Journal:  J Clin Invest       Date:  2018-01-22       Impact factor: 14.808

6.  Cyclic AMP potentiates vascular endothelial cadherin-mediated cell-cell contact to enhance endothelial barrier function through an Epac-Rap1 signaling pathway.

Authors:  Shigetomo Fukuhara; Atsuko Sakurai; Hideto Sano; Akiko Yamagishi; Satoshi Somekawa; Nobuyuki Takakura; Yoshihiko Saito; Kenji Kangawa; Naoki Mochizuki
Journal:  Mol Cell Biol       Date:  2005-01       Impact factor: 4.272

7.  FoxH1 negatively modulates flk1 gene expression and vascular formation in zebrafish.

Authors:  Jayoung Choi; Linda Dong; Janice Ahn; Diem Dao; Matthias Hammerschmidt; Jau-Nian Chen
Journal:  Dev Biol       Date:  2007-01-20       Impact factor: 3.582

8.  Endothelial CCR2 signaling induced by colon carcinoma cells enables extravasation via the JAK2-Stat5 and p38MAPK pathway.

Authors:  Monika Julia Wolf; Alexandra Hoos; Judith Bauer; Steffen Boettcher; Markus Knust; Achim Weber; Nicole Simonavicius; Christoph Schneider; Matthias Lang; Michael Stürzl; Roland S Croner; Andreas Konrad; Markus G Manz; Holger Moch; Adriano Aguzzi; Geert van Loo; Manolis Pasparakis; Marco Prinz; Lubor Borsig; Mathias Heikenwalder
Journal:  Cancer Cell       Date:  2012-07-10       Impact factor: 31.743

9.  Functional assessment of von Willebrand factor expression by cancer cells of non-endothelial origin.

Authors:  Anahita Mojiri; Konstantin Stoletov; Maria Areli Lorenzana Carrillo; Lian Willetts; Saket Jain; Roseline Godbout; Paul Jurasz; Consolato M Sergi; David D Eisenstat; John D Lewis; Nadia Jahroudi
Journal:  Oncotarget       Date:  2017-02-21

Review 10.  Niclosamide: Beyond an antihelminthic drug.

Authors:  Wei Chen; Robert A Mook; Richard T Premont; Jiangbo Wang
Journal:  Cell Signal       Date:  2017-04-04       Impact factor: 4.315

View more
  1 in total

1.  High-content screening of active components of Traditional Chinese Medicine inhibiting TGF-β-induced cell EMT.

Authors:  Mengzhen Xu; Qinghua Cui; Wen Su; Dan Zhang; Jiaxu Pan; Xiangqi Liu; Zheng Pang; Qingjun Zhu
Journal:  Heliyon       Date:  2022-08-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.